This is a community-generated profile. If you would like to claim it, please .
Skyhawk
RNA-modifying small molecule therapeutics for treating cancer & neurological conditions51-200 EmployeesActively Hiring
Skyhawk Funding
$133M
11 round
Skyhawk is active in the following markets / industries: B2B and professional services. The company has secured funding across 1 rounds, totaling in an amount of $133M. Their most recent funding was raised on September 14, 2021.
Funding Rounds
S
$133000000